IL-6 promoter functional polymorphism -572C/G affects spontaneous clearance of hepatitis B virus infection

Clinical Laboratory

Volumn 60, Issue 11, 2014, Pages 1903-1907

  Lu, Yanjun ^a   Peng, Jing ^a   Wang, Chunyu ^a   Zhu, Yaowu ^a   Wang, Feng ^a   Sun, Ziyong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Genotype; Hepatitis B virus; Interleukin 6; Single nucleotide polymorphism

Indexed keywords

HEPATITIS B VIRUS;

IL6 PROTEIN, HUMAN; INTERLEUKIN 6;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHINA; EPIDEMIOLOGY; ETHNOLOGY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HEPATITIS B, CHRONIC; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; MALE; MIDDLE AGED; PHENOTYPE; PROMOTER REGION; REMISSION; RISK;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; GENE FREQUENCY; GENOTYPE; HEPATITIS B, CHRONIC; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERLEUKIN-6; MALE; MIDDLE AGED; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; REMISSION, SPONTANEOUS;

EID: 84914161389     PISSN: 14336510     EISSN: None     Source Type: Journal    
DOI: 10.7754/Clin.Lab.2014.140311     Document Type: Article

References (26)

1. Höhler T, Gerken G, Notghi A, et al. HLA-DRB1' 1301 and '1302 protect against chronic hepatitis B. J Hepatol 1997;26:503-7.
2. Wang FS. Current status and prospects of studies on human genetic alleles associated with hepatitis B virus infection. World J Gastroenterol 2003;9:641-4.
3. Zhai Y, Busuttil RW, Kupiec-Weglinski JW. Liver ischemia and reperfusion injury: new insights into mechanisms of innate-adaptive immune-mediated tissue inflammation. Am J Transplant 2011;11:1563-9.
4. Rehermann B, Nascimbeni M. Immunology of hepatitis B virus and hepatitis C virus infection. Nat Rev Immunol 2005;5:215-9.
5. Hösel M, Quasdorff M, Wiegmann K, et al. Not interferon, but interleukin-6 controls early gene expression in hepatitis B virus infection. Hepatology 2009;50:1773-82.
6. Fishman D, Faulds G, Jeffery R, et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 1998;102:1369-76.
7. Giannitrapani L, Soresi M, Giacalone A, et al. IL-6-174G/C polymorphism and IL-6 serum levels in patients with liver cirrhosis and hepatocellular carcinoma. OMICS 2011;15:183-6.
8. Ribeiro CS, Visentainer JE, Moliterno RA. Association of cytokine genetic polymorphism with hepatitis B infection evolution in adult patients. Mem Inst Oswaldo Cruz 2007;102:435-40.
9. Tong Y, Wang Z, Geng Y, et al. The association of functional polymorphisms of IL-6 gene promoter with ischemic stroke: analysis in two Chinese populations. Biochem Biophys Res Commun 2010;391:481-5.
10. Terry CF, Loukaci V, Green FR. Cooperative influence of genetic polymorphisms on interleukin 6 transcriptional regulation. J Biol Chem 2000;275:18138-44.
11. Zhang G, Zhou B, Wang W, et al. A functional single-nucleotide polymorphism in the promoter of the gene encoding interleukin 6 is associated with susceptibility to tuberculosis. J Infect Dis 2012;205:1697-704.
12. Fragoso JM, Delgadillo H, Juarez-Cedillo T, et al. The interleukin 6-572 G>C (rsl800796) polymorphism is associated with the risk of developing acute coronary syndrome. Genet Test Mol Biomarkers 2010;14:759-63.
13. Castro FAI, Haimila K, Sareneva I, et al. Association of HLA-DRB 1, interleukin-6 and cyclin D1 polymorphisms with cervical cancer in the Swedish population-a candidate gene approach. Int J Cancer 2009;15:125(8):1851-8.
14. Curtin KI, Wolff RK, Herrick JS, et al. Exploring multilocus associations of inflammation genes and colorectal cancer risk using hapConstructor. BMC Med Genet 2010;11:170.
15. Zhao XM, Gao YF, Zhou Q, et al. Relationship between interleukin-6 polymorphism and susceptibility to chronic hepatitis B virus infection. World J Gastroenterol 2013;19:6888-93.
16. Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A. An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods 1991;34:105-12.
17. Hyams KC. Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis. 1995;20:992-1000.
18. Thursz M, Yee L, Khakoo S. Understanding the host genetics of chronic hepatitis B and C. Semin Liver Dis 2011;31:115-27.
19. Lin TM, Chen CJ, Wu MM, et al. Hepatitis B virus markers in Chinese twins. Anticancer Res 1989;9:737-41.
20. Xu J, Zhang S, Zhang Z, et al. TNF-alpha promoter region polymorphisms affect HBV virus clearance in southern Chinese. Clin Chim Acta 2013;425:90-2.
21. Kamatani Y, Wattanapokayakit S, Ochi H, et al. A genome-wide association study identifies variants in the HLA-DP locus associated with chronic hepatitis B in Asians. Nature Genetics 2009;41:591-5.
22. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999;284:825-9.
23. Brull DJ, Montgomery HE, Sanders J, et al. Interleukin-6 gene - 174g > c and -572g > c promoter polymorphisms are strong predictors of plasma interleukin-6 levels after coronary artery bypass surgery. Arterioscler Thromb Vasc Biol 2001;21:1458-63.
24. Gu W, Du DY, Huang J, et al. Identification of interleukin-6 promoter polymorphisms in the Chinese Han population and their functional significance. Crit Care Med 2008;36:1437-43.
25. He MX, Yang WL, Zhang MM, et al. Association between interleukin-6 gene promoter -572C/G polymorphism and the risk of sporadic Alzheimer's disease. Neurol Sci 2010;31:165-8.
26. Nattermann J, Vogel M, Berg T, et al. Effect of the interleukin-6 C174G gene polymorphism on treatment of acute and chronic hepatitis C in human immunodeficiency virus coinfected patients. Hepatology 2007;46:1016-25